- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06778369
Triangular Exclusion Technique in Isolated Posterior Mitral Valve Leaflet Prolapse for Mitral Valve Repair
The goal of this clinical trial is to learn if surgical method done to repair one of the heart valve called mitral valve disease during open heart surgery
The main questions aims to answer is:
Does this method is safe and effective for long time and can be used in special cases of mitral valve surgery ? participants come to clinic to be checked clinically and radiologcally every month by the surgeon till 12 month
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
El Sharkia
-
Zagazig, El Sharkia, Egypt, 44519
- cardiothorathic surgery department -faculty of medecine-zagazig univeristy-Egypt
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- varying degrees of degenerative MV regurgitation, ranging from moderate to severe or severe caused by isolated prolapse of the posterior MV leaflet
- concomitant tricuspid annuloplasty
Exclusion Criteria:
- with Mitral Valve stenosis or any other manifestation of mitral regurgitation pathology.
- individuals requiring surgical intervention for the aortic or pulmonary valves
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: traingular exclusion technique
Triangular exclusion technique in isolated posterior mitral valve leaflet prolapse for mitral valve repair
|
The prolapsed part of the posterior leaflet is inverted and excluded, not resected toward the left ventricle, and the margins of the prolapsed part are sutured to each other's using proline 5/0, extending from the posterior leaflet edge to the posterior annulus.
Then the posterior annulus is reinforced with an annuloplasty band using a treated strip of pericardium.
The determination of suitable ring size is subsequently predicated upon the assessment of inter-commissural distance surface area and the anterior leaflet, utilizing sizers that are correlated with typical mitral geometry.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
degree of postoperative mitral valve regurgitation following Triangular Exclusion Technique
Time Frame: about 13 months From enrolment to the end of surgical procedure about one month follow up Echo done after 6 and 12 months so total time frame about 13 months duration
|
Suggested Quality Metrics for Interventions for Mitral Regurgitation
|
about 13 months From enrolment to the end of surgical procedure about one month follow up Echo done after 6 and 12 months so total time frame about 13 months duration
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: sameh saeed, lecturer, cardiothoracic surgery department-faculty of medecine-Zagazig univeristy-Egypt
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ZU-IRB # 11120-20-9-2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mitral Valve Posterior Leaflet Prolapse
-
Edwards LifesciencesICON plcTerminatedSevere Degenerative Mitral Regurgitation Due to Mid-segment Posterior Leaflet ProlapseGermany, Spain, Switzerland
-
Edwards LifesciencesTerminatedMitral Leaflet ProlapseItaly
-
Centre Hospitalier Universitaire, AmiensRecruitingDegenerative Mitral Regurgitation (MR) Due to Leaflet ProlapseFrance
-
IRCCS San RaffaeleCompletedMitral Valve Prolapse Syndrome | Arrhythmogenic Bileaflet Mitral Prolapse | Mitral Valve DisorderItaly
-
Centro Cardiologico MonzinoAzienda Ospedaliero-Universitaria di Parma; Policlinico SS Annunziata di ChietiActive, not recruitingMitral Regurgitation | Mitral Valve ProlapseItaly
-
IRCCS Policlinico S. DonatoRecruitingMitral Valve Prolapse | Myxomatous Mitral Valve DegenerationItaly
-
NeoChordRecruitingHeart Valve Diseases | Mitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve Prolapse | Mitral Valve DiseaseGermany, Greece, Switzerland
-
Lawson Health Research InstituteUnknownMitral Regurgitation | Mitral Valve Prolapse | Mitral Valve Disease
-
Eric Y. Yang, MD PhDUnknownMitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve Prolapse | Ventricular Remodeling | Mitral Valve Disease | Degenerative Mitral Valve Disease | Chronic Mitral Disease | Myxomatous Mitral Valve DegenerationUnited States
-
Edwards LifesciencesCompletedMitral Valve Insufficiency | Mitral Valve Prolapse | Mitral Valve RegurgitationPoland
Clinical Trials on traingular exclusion technique in mitral valve repair
-
National Cardiovascular Center Harapan Kita Hospital...Unknown
-
Michele De BonisCompletedMitral Valve DiseaseItaly
-
China National Center for Cardiovascular DiseasesCompletedPediatric Cardiac Surgery | Mitral Regurgitation (MR)China
-
Michele De BonisCompletedMitral Valve RegurgitationItaly
-
Michele De BonisCompletedDegenerative Mitral Valve DiseaseItaly
-
Hangzhou Valgen Medtech Co., LtdDonawa LifescienceRecruiting
-
Southern Illinois UniversityWithdrawnMyocardial Infarction | Mitral RegurgitationUnited States
-
Hong LiuUnknownPulmonary Arterial Hypertension | Mitral InsufficiencyChina
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Icahn School of Medicine at Mount SinaiNational Heart, Lung, and Blood Institute (NHLBI); Canadian Institutes of Health... and other collaboratorsCompletedCoronary Artery Disease | Mitral Valve InsufficiencyUnited States, Canada